A new wave of mergers and acquisitions is reshaping the veterinary care, diagnostics, and companion animal health landscape across the US, Europe, and Asia. Four significant deals announced in early August 2026 signal that industry consolidation is accelerating even as veterinary visit volumes decline — driven by the need for scale, technology investment, and cross-border expansion.
In the United States, Bond Vet and Small Door Veterinary have completed a merger creating one of the largest premium veterinary networks in the country. The combined entity operates more than 55 clinics across the Northeast, Mid-Atlantic, and Midwest, serving over 500,000 pets with 170+ veterinarians. Small Door co-founder Florent Peyre will lead the merged company as CEO. Notably, the two New York-founded companies were direct competitors in overlapping markets — their decision to merge rather than acquire signals that standalone premium clinic economics are increasingly challenging. Both brands will continue operating independently in the near term, with gradual operational integration planned.
Zoetis has signed an agreement to acquire VitalRADS, a veterinary teleradiology platform serving more than 1,800 active customers including corporate clinics, independent practices, and universities. The acquisition, expected to close in Q3 2026, will integrate VitalRADS’s 24/7 specialist teleradiology, mobile ultrasound, and cloud-based image storage into Zoetis’s Global Diagnostics portfolio — building an end-to-end Virtual Reference Lab that complements its existing Vetscan Imagyst and Vetscan Opticell AI platforms. In Europe, UK-based VetPartners acquired Medivet’s Spanish operations, adding 46 clinics to its network. India’s Viyash Scientific, through its subsidiary Alivira Animal Health, acquired Milan-based pet healthcare firm BioForLife for $19.5 million, gaining presence in over 80% of Italian veterinary clinics and a platform to expand Alivira’s product pipeline across Europe, the Middle East, Asia, and Latin America.
